相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶现货试剂/标准品,库存足,周末发货Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
1253186-56-9
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg/50 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥743.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥400.0 |
| 规格: | 5 mg | 产品价格: | ¥850.0 |
| 规格: | 10 mg | 产品价格: | ¥1360.0 |
| 规格: | 25 mg | 产品价格: | ¥2720.0 |
| 规格: | 50 mg | 产品价格: | ¥4080.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
GSK-7975A
CAS No. : 1253186-56-9
MCE 国际站:GSK-7975A
产品活性:GSK-7975A是高效有口服活性的 CRAC 通道抑制剂。
研究领域:Membrane Transporter/Ion Channel | Neuronal Signaling
作用靶点:Calcium Channel
In Vitro: GSK-7975A reduces FcεRI-dependent Ca2+ influx and 3 μM GSK-7975A reduces the release of histamine, leukotriene C4, and cytokines (IL-5/-8/-13 and TNFα) by up to 50%. GSK-7975A inhibits mediator release from mast cells, and pro-inflammatory cytokine release from T-cells in a variety species. GSK-7975A completely inhibits calcium influx through CRAC channels. This leads to inhibition of the release of mast cell mediators and T-cell cytokines from multiple human and rat preparations. Mast cells from guinea-pig and mouse preparations are not inhibited by GSK-7975A; however cytokine release is fully blocked from T-cells in a mouse preparation. GSK-7975A inhibits toxin-induced activation of ORAI1 and/or activation of Ca2+ currents after Ca2+ release, in a concentration-dependent manner, in mouse and human pancreatic acinar cells (inhibition >90% of the levels observed in control cells). GSK-7975A also prevents activation of the necrotic cell death pathway in mouse and human pancreatic acinar cells.
In Vivo: GSK-7975A inhibits local and systemic features of acute pancreatitis in TLCS-AP, CER-AP, FAEE-AP, in dose- and time-dependent manners.? GSK-7975A significantly reduces increases in serum amylase, IL6, and pancreatic MPO levels; lung MPO is reduced significantly by low dose only. GSK-7975A markedly reduces pancreatic histopathology in TLCS-AP, CER-AP, and FAEE-AP.
相关产品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Membrane Transporter/Ion Channel Compound Library | Neuronal Signaling Compound Library | Orally Active Compound Library | Neuroprotective Compound Library | Calcium Channel Blocker Library | Antihypertensive Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Ion Channel Compound Library | Thapsigargin | Ionomycin | L-Ascorbic acid | Minocycline hydrochloride | Verapamil | 2-Aminoethyl diphenylborinate | Acetylcholine chloride | GSK1016790A | Nifedipine | Fasudil Hydrochloride | Ebselen | Halofuginone | Tetrandrine | Carbamazepine | Ruthenium red | CDN1163 | ISX-9 | Gabapentin | TPC2-A1-N | Bay K 8644 | Ethacrynic acid | L-Phenylalanine | Istaroxime hydrochloride | Amlodipine | Digitoxin | Diltiazem hydrochloride | Cromolyn sodium
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验DNA extraction from Mutation Detection Enhancement (MDE) Gel Stained with Silver Nitrate
'); these amplified a 146-bp fragment of exon 3 of the CTNNB1 gene, encompassing the sequence for GSK-3¦Â phosphorylation. The PCR conditions consisted of 1 cycle at 95˚C for 5 min; 40 cycles at 95˚C for30 sec, 55˚C for 45 sec, and 72˚C for 75 sec; at a final
。若RSL3、ML162或ML210等结构不同的化合物均能引起脂质过氧化,并且可以被Fer-1或Lip-1挽救,更能支撑GPX4依赖性铁死亡。 这些化合物主要用于机制研究,其稳定性、体内暴露和安全性存在局限,体外有效不能直接等同于具有临床治疗价值。 5. FIN56与FINO₂ 作用特点:同时影响多条氧化防线 FIN56可促进GPX4蛋白减少,并影响甲羟戊酸途径和辅酶Q相关代谢。它适合研究GPX4与辅酶Q防线之间的关系,但不适合用来证明单一靶点。 FINO₂不直接抑制System Xc⁻或结合GPX
【翻译】Development trends for monoclonal antibody cancer therapeutics
two murine, Y-90 ibritumomab tiuxetan (Zevalin; Biogen Idec) and I-131 tositumomab (Bexxar; Corixa/GSK), and one chimeric, I-131 ch-TNT (Shanghai Medipharm Biotech) — have been approved for non-Hodgkin's lymphoma or lung cancer, but only 14% of anticancer
技术资料暂无技术资料 索取技术资料


















